230 related articles for article (PubMed ID: 26699747)
1. Antifungal Activity of Salvia miltiorrhiza Against Candida albicans Is Associated with the Alteration of Membrane Permeability and (1,3)-β-D-Glucan Synthase Activity.
Lee HS; Kim Y
J Microbiol Biotechnol; 2016 Mar; 26(3):610-7. PubMed ID: 26699747
[TBL] [Abstract][Full Text] [Related]
2. Emodin Reduces the Activity of (1,3)-
Janeczko M
Pol J Microbiol; 2018; 67(4):463-470. PubMed ID: 30550232
[TBL] [Abstract][Full Text] [Related]
3.
Lee HS; Kim Y
J Microbiol Biotechnol; 2017 Feb; 27(2):395-404. PubMed ID: 28100900
[TBL] [Abstract][Full Text] [Related]
4.
Lee HS; Kim Y
J Microbiol Biotechnol; 2020 Dec; 30(12):1827-1834. PubMed ID: 33148941
[No Abstract] [Full Text] [Related]
5.
Lee HS; Kim Y
J Microbiol Biotechnol; 2020 Jul; 30(7):967-973. PubMed ID: 32347080
[TBL] [Abstract][Full Text] [Related]
6. Interface of Candida albicans biofilm matrix-associated drug resistance and cell wall integrity regulation.
Nett JE; Sanchez H; Cain MT; Ross KM; Andes DR
Eukaryot Cell; 2011 Dec; 10(12):1660-9. PubMed ID: 21666076
[TBL] [Abstract][Full Text] [Related]
7. The lipopeptide antimycotic, cilofungin modulates the incorporation of glucan-associated proteins into the cell wall of Candida albicans.
Angiolella L; Simonetti N; Cassone A
J Antimicrob Chemother; 1994 Jun; 33(6):1137-46. PubMed ID: 7928807
[TBL] [Abstract][Full Text] [Related]
8. Antifungal Activity Directed Toward the Cell Wall by 2-Cyclohexylidenhydrazo- 4-Phenyl-Thiazole Against Candida albicans.
de Sá NP; Pôssa AP; Perez P; Ferreira JMS; Fonseca NC; Lino CI; Cruz LB; de Oliveira RB; Rosa CA; Borelli BM; Mylonakis E; Fuchs BB; Johann S
Infect Disord Drug Targets; 2019; 19(4):428-438. PubMed ID: 29852876
[TBL] [Abstract][Full Text] [Related]
9. Elevation of cell wall chitin via Ca
Han Q; Wang N; Pan C; Wang Y; Sang J
Mol Microbiol; 2019 Sep; 112(3):960-972. PubMed ID: 31240791
[TBL] [Abstract][Full Text] [Related]
10. Discovery of cercosporamide, a known antifungal natural product, as a selective Pkc1 kinase inhibitor through high-throughput screening.
Sussman A; Huss K; Chio LC; Heidler S; Shaw M; Ma D; Zhu G; Campbell RM; Park TS; Kulanthaivel P; Scott JE; Carpenter JW; Strege MA; Belvo MD; Swartling JR; Fischl A; Yeh WK; Shih C; Ye XS
Eukaryot Cell; 2004 Aug; 3(4):932-43. PubMed ID: 15302826
[TBL] [Abstract][Full Text] [Related]
11. Development of
Lee HS; Kim Y
J Microbiol Biotechnol; 2018 Mar; 28(3):482-490. PubMed ID: 29316739
[No Abstract] [Full Text] [Related]
12. Short-Term Antifungal Treatments of Caprylic Acid with Carvacrol or Thymol Induce Synergistic 6-Log Reduction of Pathogenic Candida albicans by Cell Membrane Disruption and Efflux Pump Inhibition.
Bae YS; Rhee MS
Cell Physiol Biochem; 2019; 53(2):285-300. PubMed ID: 31334617
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors.
Onishi J; Meinz M; Thompson J; Curotto J; Dreikorn S; Rosenbach M; Douglas C; Abruzzo G; Flattery A; Kong L; Cabello A; Vicente F; Pelaez F; Diez MT; Martin I; Bills G; Giacobbe R; Dombrowski A; Schwartz R; Morris S; Harris G; Tsipouras A; Wilson K; Kurtz MB
Antimicrob Agents Chemother; 2000 Feb; 44(2):368-77. PubMed ID: 10639364
[TBL] [Abstract][Full Text] [Related]
14. Evaluating β-1,3-glucan synthesis inhibition using emulsion formation as an indicator.
Nerome S; Yokota N; Ojima Y; Azuma M
J Microbiol Methods; 2021 Nov; 190():106327. PubMed ID: 34517039
[TBL] [Abstract][Full Text] [Related]
15. Phenotype in Candida albicans of a disruption of the BGL2 gene encoding a 1,3-beta-glucosyltransferase.
Sarthy AV; McGonigal T; Coen M; Frost DJ; Meulbroek JA; Goldman RC
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():367-376. PubMed ID: 9043114
[TBL] [Abstract][Full Text] [Related]
16. Myricetin Disturbs the Cell Wall Integrity and Increases the Membrane Permeability of
Lee HS; Kim Y
J Microbiol Biotechnol; 2022 Jan; 32(1):37-45. PubMed ID: 34750288
[TBL] [Abstract][Full Text] [Related]
17. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
Bartizal K; Abruzzo G; Trainor C; Krupa D; Nollstadt K; Schmatz D; Schwartz R; Hammond M; Balkovec J; Vanmiddlesworth F
Antimicrob Agents Chemother; 1992 Aug; 36(8):1648-57. PubMed ID: 1416847
[TBL] [Abstract][Full Text] [Related]
18. Anti-Candida albicans natural products, sources of new antifungal drugs: A review.
Zida A; Bamba S; Yacouba A; Ouedraogo-Traore R; Guiguemdé RT
J Mycol Med; 2017 Mar; 27(1):1-19. PubMed ID: 27842800
[TBL] [Abstract][Full Text] [Related]
19. Analysis of validamycin as a potential antifungal compound against Candida albicans.
Guirao-Abad JP; Sánchez-Fresneda R; Valentín E; Martínez-Esparza M; Argüelles JC
Int Microbiol; 2013 Dec; 16(4):217-25. PubMed ID: 25102722
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of the
Guirao-Abad JP; Pujante V; Sánchez-Fresneda R; Yagüe G; Argüelles JC
J Med Microbiol; 2019 Oct; 68(10):1479-1488. PubMed ID: 31380734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
